1. | Altmedsresearch | |
2. | dunnie36 | |
3. | bluewatercloud | |
4. | sevap476 |
1. | Altmedsresearch | |
2. | dunnie36 | |
3. | bluewatercloud | |
4. | sevap476 |
1. | dunnie36 01/25/2018 R.W. Baird reiterates Outperform rating; PT lowered to $253 from $332 |
2. | bluewatercloud 02/12/2018 Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients with Compensated Cirrhosis |
3. | Altmedsresearch 09/12/2017 investigating claims |
4. | Altmedsresearch 02/01/2018 FDA adds Boxed Warning to highlight correct dosing of Ocaliva for patients with a rare chronic liver disease |
5. | Altmedsresearch 02/14/2018 $ICPT Earnings today |